CHRM4 and prostate cancer: Moreover, patients whose prostate tumors showed high NGF and CHRM4 mRNA expression levels also exhibited high metastatic potential (Fig. 6d) and a high pathological grade based on the Gleason score (PathGGS) (Fig. 6e), as validated in the Taylor prostate cancer datasets30.